Nextgen Pharmaceutical and Formulations Private Limited
About Nextgen Pharmaceutical and Formulations Private Limited
Data last updated:
Nextgen Pharmaceutical and Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2016PTC035508. Its GSTIN is 23AAFCN2024D1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Vikrant Mansana and Meenakshi Shrimali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 116 /A Surya Dev Nagar, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.35 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹2.18 Lakh (net margin -5.3%) and EBITDA of -₹2.18 Lakh (EBITDA margin -5.3%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address116 /A Surya Dev Nagar, Indore, Madhya Pradesh, India – 452009
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nextgen Pharmaceutical and Formulations Private Limited
The main business activity of Nextgen Pharmaceutical and Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nextgen Pharmaceutical and Formulations Private Limited FY 2025 filings available
Nextgen Pharmaceutical and Formulations Private Limited reported revenue of ₹41.35 Lakh (up 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nextgen Pharmaceutical and Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 14% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nextgen Pharmaceutical and Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.18 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nextgen Pharmaceutical and Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nextgen Pharmaceutical and Formulations are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Big Laboratories Private Limited | ₹41.45 Lakh (FY 2021) | •••• | •••• | -48.0% | •••• | New Delhi, Delhi, India |
| Franco Indian Therapeutics Pvt. Ltd. | ₹41.44 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Kolkata, West Bengal, India |
| Genlyfe Healthcare Private Limited | ₹41.44 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Genomics Healthcare Private Limited | ₹41.41 Lakh (FY 2020) | •••• | •••• | 30.0% | •••• | Howrah, West Bengal, India |
| Glary Pharmaceuticals Private Limited | ₹41.39 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Lucknow, Uttar Pradesh, India |
| Nextgen Pharmaceutical and Formulations Private Limited this company | ₹41.35 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Indore, Madhya Pradesh, India |
| Unimartpharma Private Limited | ₹41.33 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Aorta Laboratories Private Limited | ₹41.3 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | West Mumbai, Maharashtra, India |
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | •••• | •••• | 13.0% | •••• | Amritsar, Punjab, India |
| Zynext Pharmaceuticals Private Limited | ₹41.23 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Bhopal, Madhya Pradesh, India |
| Nascent Lifescience Private Limited | ₹41.21 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Nextgen Pharmaceutical and Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations Private Limited is audited by M S SINGHATWADIA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S SINGHATWADIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikrant Mansana | Director | 22 Mar 2024 | 2 Years 6 Months | Current |
| Meenakshi Shrimali | Director | 22 Mar 2024 | 2 Years 6 Months | Current |
| Rajesh Verma | Director | 09 Mar 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Nextgen Pharmaceutical and Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nextgen Pharmaceutical and Formulations Private Limited
Employment history and EPFO contributions of people linked to Nextgen Pharmaceutical and Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations Private Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Meenakshi Shrimali ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Nextgen Pharmaceutical and Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nextgen Pharmaceutical and Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nextgen Pharmaceutical and Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCN2024D1Z6 | Madhya Pradesh | Active | 07 Mar 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nextgen Pharmaceutical and Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nextgen Pharmaceutical and Formulations Private Limited
Nextgen Pharmaceutical and Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 March 2016 (10+ years old) and is registered under CIN U24230MP2016PTC035508.
Nextgen Pharmaceutical and Formulations reported revenue of ₹41.35 Lakh for FY 2024 (up 14% YoY).
Nextgen Pharmaceutical and Formulations has 3 current directors:
- Vikrant Mansana - Director
- Meenakshi Shrimali - Director
- Rajesh Verma - Director
Nextgen Pharmaceutical and Formulations reported a net loss of ₹2.18 Lakh (net margin -5.3%) and EBITDA of -₹2.18 Lakh (EBITDA margin -5.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nextgen Pharmaceutical and Formulations is 88% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nextgen Pharmaceutical and Formulations is 23AAFCN2024D1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Nextgen Pharmaceutical and Formulations is U24230MP2016PTC035508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nextgen Pharmaceutical and Formulations was incorporated on 09 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Nextgen Pharmaceutical and Formulations by revenue are Big Laboratories Private Limited, Franco Indian Therapeutics Pvt. Ltd, Genlyfe Healthcare Private Limited, Genomics Healthcare Private Limited, Glary Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Meenakshi Shrimali ceased to be Additional Director on 29 Sep 2024. Vikrant Mansana ceased to be Additional Director on 29 Sep 2024. Ajay Shrimali ceased to be Director on 28 Mar 2024. Nextgen Pharmaceutical and Formulations has 7 board changes on record in total.
The registered office of Nextgen Pharmaceutical and Formulations is at 116 A Surya Dev Nagar, Indore, Madhya Pradesh, India – 452009.